Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

NCT06298734

Conditions: Advanced Melanoma, Melanoma, Melanoma (Skin), +12 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

NCT06940739

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +17 more
Locations: SCRI Oncology Partners- Denver Denver, Colorado, United States

UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

Greenslopes Private Hospital Greenslopes, Queensland, Australia

View Trial Details

Recruiting

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

NCT06967961

Conditions: Adenocarcinoma of Endometrium, Carcinoma, Carcinoma, Transitional Cell, +41 more
Locations: Oncopole Claudius Regaud, IUCT-O Toulouse, France

View Trial Details

Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NCT05896839

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Keck Medicine of USC Koreatown Los Angeles, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 26 locations

View Trial Details

Recruiting

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

NCT07405086

Conditions: Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

NCT02479698

Conditions: Acquired Immunodeficiency Syndrome, Adenocarcinoma, BK Virus Infection, +43 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Rural Adult and Youth Sun Protection Study

NCT06439979

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations: University of Utah Salt Lake City, Utah, United States

West Virginia University Morgantown, West Virginia, United States

View Trial Details

Recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

NCT06479811

Conditions: Carcinoma, Cranial Nerve Diseases, Esthesioneuroblastoma, +43 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker

NCT07266142

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: UZLeuven, Department of Dermatology Leuven, Vlaams-Brabant, Belgium

View Trial Details

Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

NCT06414590

Conditions: Eye Diseases, Eye Neoplasms, Locally Advanced Unresectable Uveal Melanoma, +12 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

Wills Eye Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions